Mycoplasma pneumoniae in Community-Acquired Lower Respiratory Tract Infections
- 60 Downloads
To determine the role of Mycoplasma pneumoniae (M. pneumoniae) in pediatric lower respiratory tract infections (LRTIs) employing serological tests and polymerase chain reaction (PCR) analysis.
In this prospective study, 200 children aged 6 mo to 12 y hospitalized with acute LRTIs were investigated for M. pneumoniae. Serum samples were collected for serological analysis of M. pneumoniae. Throat swab samples were obtained on admission to amplify 277-base pair region of 16S rDNA gene of M. pneumoniae by PCR.
In the present study, 40(26.1%) children <5 y and 28(59.5%) children ≥5 y age group were positive for M. pneumoniae infection and this difference was statistically significant (P < 0.001). M. pneumoniae was positive in 32(41%) female and 36(29.5%) male children though this difference was statistically insignificant (P = 0.12). The clinical profile across M. pneumoniae positive and negative cases were comparable except for presence of chest pain which was statistically significant (P = 0.023). None of the radiological findings was statistically associated with incidence of M. pneumoniae infection. Serological evidence of acute M. pneumoniae infection was observed in 64(32%) patients with sensitivity 66.6% and specificity 70.1% while PCR positivity in 12(6%) patients with sensitivity 12.5% and specificity 97%. Together, serology and PCR detected M.pneumoniae infection in 68(34%) patients.
The present study underlines the role of M. pneumoniae in children with community- acquired LRTIs and more particularly in ≥5 y of age.
KeywordsMycoplasma pneumoniae Polymerase chain reaction Pediatric Serology
SK: Conceptualized and designed the study, designed data collection instruments, collected data, carried out initial analyses, drafted the initial manuscript, and approved the final manuscript as submitted; IBG and GRS: carried out the further analyses, reviewed and revised the manuscript, and approved the final manuscript as submitted. SK will act as guarantor for this paper.
Compliance with Ethical Standards
Conflict of Interest
Source of Funding
University Grants Commission, Bahadurshah Zafar Marg, New Delhi, India, sanctioned the financial assistance for this major research project vide sanction letter No. F.No. 32–575/2006(SR), dated: 07–03-2007.
- 2.Kogoj R, Mrvic T, Praprotnik M, Kese D. Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014. Euro Surveill. 2015;20 https://doi.org/10.2807/1560-7917.ES.2015.20.37.30018.
- 11.Kumar S, Saigal SR, Sethi GR. Rapid diagnosis of Mycoplasma pneumoniae by polymerase chain reaction in community- acquired lower respiratory tract infections. Trop Doct. 2011;41:160–2.Google Scholar
- 16.Maheshwari M, Kumar S, Sethi GR, Bhalla P. Detection of Mycoplasma pneumoniae in children with lower respiratory tract infections. Trop Doct. 2011;41:40–2.Google Scholar
- 18.Principi N, Esposito S, Blasi F, Allegra L; The Mowgli Study Group. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Clin Infect Dis. 2001;32:1281–9.Google Scholar
- 19.Deerojanawong J, Prapphal N, Suwanjutha S, Lochindarat S, Chantarojanasiri T, Kunakorn M. Prevalence and clinical features of Mycoplasma pneumoniae in Thai children. J Med Assoc Thail. 2006;89:1641–7.Google Scholar
- 23.Beersma MFC, Dirven K, van Dam AP, Templeton KE, Class ECJ, Goosens H. Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae specific immunoglobulin G(IgG) and IgM antibodies, with PCR used as the gold standard. J Clin Microbiol. 2005;43:2277–85.CrossRefPubMedPubMedCentralGoogle Scholar